EU Rejects Cymbalta For Fibromyalgia Treatment
In a blow to Eli Lilly & Co., the European Union's drug-regulating body has recommended against allowing the pharmaceutical giant to market Cymbalta as a fibromyalgia treatment after finding that the...To view the full article, register now.
Already a subscriber? Click here to view full article